Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
**Background/Objectives:** Until now, no meta-analysis has been published to evaluate the diagnostic performance of next-generation sequencing (NGS) panel using circulating tumor (ctDNA) in patients with advanced non-small cell lung cancer (aNSCLC). The aim of the study was to carry out a systematic...
Saved in:
| Main Authors: | Mariana M. Sebastião, Rodrigo S. Ho, João Paulo V. de Carvalho, Micha Nussbaum |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2020-09-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/jheor.2020.17088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Issues of Next-Generation Sequencing-Based Circulating Tumor DNA Analysis in Colorectal Cancer
by: Narmadha Rathnasamy, et al.
Published: (2024-10-01) -
Next-Generation Sequencing Infertility Panel in Turkey: First Results
by: Ikbal Atli E, et al.
Published: (2025-03-01) -
Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
by: Holly LaDuca, et al.
Published: (2017-01-01) -
Development and validation of a next-generation sequencing panel for clinical pharmacogenetics
by: Luis Ramudo-Cela, et al.
Published: (2020-11-01) -
Development of next generation sequencing panel for UMOD and association with kidney disease.
by: Caitlin Bailie, et al.
Published: (2017-01-01)